8-K: Scilex Holding Company Implements 1-for-35 Reverse Stock Split to Regain Nasdaq Compliance

Scilex Holding Company enacted a 1-for-35 reverse stock split of its common stock, effective April 15, 2025, to meet Nasdaq's minimum bid price requirement.

Summary

• Scilex Holding Company implemented a 1-for-35 reverse stock split of its common stock, effective April 15, 2025.
• The reverse stock split aims to regain compliance with the Nasdaq Capital Market's minimum bid price requirement of $1.00 per share.
• The company's stockholders approved the reverse stock split at a Special Meeting held on March 19, 2025, authorizing a range of 1-for-14 to 1-for-50.
• The Board of Directors set the ratio at 1-for-35 on April 3, 2025.
• No fractional shares will be issued; instead, shareholders will receive cash equal to the fractional share multiplied by the closing sales price on April 14, 2025.
• The trading symbol for the common stock will remain SCLX, but the CUSIP number will change to 80880W205.
• The reverse stock split will also affect the company's outstanding warrants, stock options, and senior secured convertible notes, with proportionate adjustments to exercise or conversion prices.
• For the publicly traded warrants (SCLXW), every 35 warrants will be exercisable for one share of common stock at an exercise price of $402.50 per share.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the reverse stock split is a necessary step to maintain Nasdaq listing, it also reflects underlying concerns about the company's stock price. The impact on investors is mixed, with potential for both positive and negative outcomes.

Positives

• The reverse stock split is intended to help Scilex Holding Company regain compliance with Nasdaq's minimum bid price requirement, which is crucial for continued listing.
• Existing shareholders' percentage ownership interest in the company will not be significantly affected, except for minor changes due to the elimination of fractional shares.

Negatives

• The reverse stock split may be perceived negatively by some investors as it is often a sign of a struggling stock price.
• The adjusted warrant exercise price of $402.50 may make the warrants less attractive to investors.

Risks

• There is no guarantee that the reverse stock split will successfully increase the stock price and maintain compliance with Nasdaq listing requirements.
• The company's stock price could decline further, potentially leading to delisting from the Nasdaq Capital Market.

Future Outlook

The company expects the common stock to begin trading on a reverse stock split-adjusted basis on the Nasdaq Capital Market on April 15, 2025. The company hopes that the reverse stock split will increase the stock price and maintain compliance with Nasdaq listing requirements.

Industry Context

Reverse stock splits are a common strategy for companies facing delisting from exchanges due to low stock prices. Other companies in the biotech or pharmaceutical industries that have implemented reverse stock splits include companies such as Bioblast Pharma and Diffusion Pharmaceuticals. The success of a reverse stock split depends on various factors, including the company's underlying financial health and future growth prospects.

Comparison to Industry Standards

• Compared to other companies implementing reverse stock splits, the 1-for-35 ratio is within a typical range.
• For example, Bioblast Pharma implemented a 1-for-25 reverse stock split, while Diffusion Pharmaceuticals executed a 1-for-50 reverse stock split.
• The primary goal is usually to regain compliance with exchange listing requirements, similar to Scilex's situation.

Stakeholder Impact

• Shareholders will experience a reduction in the number of shares they own, but their percentage ownership will remain largely the same.
• Warrant holders will see an adjustment in the exercise price and the number of shares they can acquire.
• Employees holding stock options will also be affected by the reverse stock split, with adjustments to the number of shares and exercise prices.

Next Steps

• Stockholders of record will receive information from Continental Stock Transfer & Trust Company regarding their stock ownership following the Reverse Stock Split and cash in lieu of fractional share payments, if applicable.
• The company will monitor the stock price to ensure continued compliance with Nasdaq listing requirements.

Key Dates

Keywords

reverse stock split, Scilex Holding Company, Nasdaq, minimum bid price, compliance, SCLX, SCLXW, warrants, stock options